EUVIMEDEUVIMED entdecken
Crossref

The impact of diabetes and presurgical glycemic control on wound morbidity following open complex abdominal wall reconstruction: a single-center experience

Nir Messer iD, Benjamin T Miller, Lucas R A Beffa, Clayton C Petro, David M Krpata, Serrgio Mazzola Poli de Figueiredo, Aldo Fafaj, Li-Ching Huang, Ryan C Ellis, Sara M Maskal, Ajita S Prabhu, Michael J Rosen

Hernia · 2024

DOI: 10.1007/s10029-024-03161-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hernia, 2024. Verfasst von Nir Messer und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cleveland Clinic Center for Abdominal Core Health, Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA. masrinir@gmail.com. Hauptthemen laut MEDLINE: Glycemic Control. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Numerous studies have identified diabetes mellites (DM) as a significant risk factor for postoperative wound morbidity, with suboptimal preoperative glycemic control (GC) posing an even greater risk. However, this data largely excludes ventral hernia patients. Our study examined the association between diabetes and preoperative GC and postoperative outcomes following open complex abdominal wall reconstruction (AWR). METHODS: We identified diabetic patients who had undergone open, elective, clean VHR with transversus abdominis release (TAR) and permanent synthetic mesh at the Cleveland Clinic Foundation between January 2014 and December 2023. Their 30-day outcomes were compared to non-diabetic patients undergoing the same procedure. Subsequently, diabetic patients were categorized based on GC. status: "Optimal GC" (HbA1c < 7%), "Sub-optimal GC" (HbA1c 7-8.4%), and "Poor GC" (HbA1c ≥ 8.5%) and their outcomes were compared. RESULTS: 514 patients with DM who underwent clean elective TAR were identified, of which 431 met the inclusion criteria. GC was deemed optimal in 255 patients, sub-optimal in 128, and poor in 48 patients. Demographics were similar, except for anticoagulation treatment (p = 0.014). The entire study population exhibited significantly higher rates of wound morbidities and overall complications compared to non-diabetic patients. However, rates of surgical site infection (SSI), surgical site occurrence (SSO), SSO requiring procedural intervention (SSOPI), and reoperation did not differ significantly among the three cohorts of presurgical glycemic control (p = 0.82, p = 0.46, p = 0.51, p = 0.78), respectively. No occurrence of mesh removal was documented. CONCLUSION: In general, diabetes is a marker for increased wound morbidity and complications following complex abdominal wall reconstruction. However, we could not establish a hard cutoff to justify withholding surgery in symptomatic patients based on an arbitrary HbA1C level. We believe this data is important for shared decision-making when considering AWR for symptomatic ventral hernias in diabetic patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Glycemic ControlHumansMaleFemaleMiddle AgedAgedRetrospective StudiesDiabetes MellitusAbdominal WallSurgical MeshHernia, VentralSurgical Wound InfectionHerniorrhaphyPostoperative ComplicationsRisk FactorsGlycated Hemoglobin

Stichwörter der Autor:innen

Diabetes MellitusGlycemic controlHbA1cSurgical site infectionSurgical site occurrenceVentral herniaWound morbidity

Substanzen

Glycated Hemoglobin

Autor:innen und Institutionen

  • Cleveland Clinic Center for Abdominal Core Health, Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA. masrinir@gmail.com.
  • Department of Surgery, Tel Aviv Sourasky Medical Center and Faculty of Medicine, Tel -Aviv University, Tel Aviv, Israel. masrinir@gmail.com.
  • Cleveland Clinic Center for Abdominal Core Health, Department of General Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA.
  • The Abdominal Core Health Quality Collaborative, Centennial, USA.
  • Department of Biostatistics, Vanderbilt University Medical Center, Nashville, TN, USA.

ORCID-Profile: Nir Messer

Zitieren

APA

Messer, N., Miller, B. T., Beffa, L. R. A., Petro, C. C., Krpata, D. M., de Figueiredo, S. M. P., Fafaj, A., Huang, L. C., Ellis, R. C., Maskal, S. M., Prabhu, A. S., & Rosen, M. J. (2024). The impact of diabetes and presurgical glycemic control on wound morbidity following open complex abdominal wall reconstruction: a single-center experience. Hernia. https://doi.org/10.1007/s10029-024-03161-2

Vancouver

Messer N, Miller BT, Beffa LRA, Petro CC, Krpata DM, de Figueiredo SMP, et al. The impact of diabetes and presurgical glycemic control on wound morbidity following open complex abdominal wall reconstruction: a single-center experience. Hernia. 2024. doi:10.1007/s10029-024-03161-2

BibTeX
@article{Messer2024,
  author = {Messer, Nir and Miller, Benjamin T and Beffa, Lucas R A and Petro, Clayton C and Krpata, David M and de Figueiredo, Serrgio Mazzola Poli and Fafaj, Aldo and Huang, Li-Ching and Ellis, Ryan C and Maskal, Sara M and Prabhu, Ajita S and Rosen, Michael J},
  title = {The impact of diabetes and presurgical glycemic control on wound morbidity following open complex abdominal wall reconstruction: a single-center experience},
  journal = {Hernia},
  year = {2024},
  doi = {10.1007/s10029-024-03161-2}
}
Kostenlos starten →